Prometheus Biosciences (RXDX) Buy, Sell or Hold

Prometheus Biosciences (RXDX)

199.92

-0.00 (0.00%)

as of Jun 15, 2023, 12:00:00 am Market Open.

3 watching

BUY

They make drugs to treat inflammatory bowel diseases, a big market. Last Wednesday they announced strong phase 2 trial data for a leading IBD drug. Shares soared 166% on Wednesday. This drug will mae RXDX a major pharma.

Showing 1 to 1 of 1 entries

Prometheus Biosciences (RXDX) Frequently Asked Questions

What is Prometheus Biosciences stock symbol?

Prometheus Biosciences is a American stock, trading under the symbol RXDX (previously RXDX-Q on Stockchase) on the NASDAQ (RXDX). It is usually referred to as NASDAQ:RXDX or RXDX

Is Prometheus Biosciences a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on RXDX (previously RXDX-Q on Stockchase) on Stockchase. Read the latest expert commentary for Prometheus Biosciences.

Is Prometheus Biosciences a good investment or a top pick?

Prometheus Biosciences was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Prometheus Biosciences.

Why is Prometheus Biosciences stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Prometheus Biosciences.

Is Prometheus Biosciences worth watching?

Prometheus Biosciences is covered by Stockchase experts and is worth watching.

What is Prometheus Biosciences stock price?

On 2023-06-15, Prometheus Biosciences (RXDX) stock closed at a price of $199.92.

Most Recent Experts

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Kevin Simpson

Capital Wealth Planning

Bryn Talkington

Requisite Capital Management

Andrey Omelchak

LionGuard Capital Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Prometheus Biosciences (RXDX)